PM, B., S, E., A, M., S, H., KNW, F., E, K., . . . ME, T. (2026). Clinical, in vitro, and in vivo evidence of WAPL as a cohesinopathy-associated gene and phenotypic driver of 10q22.3q23.2 genomic disorder. American journal of human genetics, 113(8), 1691. https://doi.org/10.1016/j.ajhg.2026.06.012
Chicago Style (17th ed.) CitationPM, Boone, et al. "Clinical, in Vitro, and in Vivo Evidence of WAPL as a Cohesinopathy-associated Gene and Phenotypic Driver of 10q22.3q23.2 Genomic Disorder." American Journal of Human Genetics 113, no. 8 (2026): 1691. https://doi.org/10.1016/j.ajhg.2026.06.012.
MLA (9th ed.) CitationPM, Boone, et al. "Clinical, in Vitro, and in Vivo Evidence of WAPL as a Cohesinopathy-associated Gene and Phenotypic Driver of 10q22.3q23.2 Genomic Disorder." American Journal of Human Genetics, vol. 113, no. 8, 2026, p. 1691, https://doi.org/10.1016/j.ajhg.2026.06.012.